Summary:
This acne research study is for those 16 to 65 years of age (those 17 and younger must have a parent/legal guardian to sign consent) who have moderate to severe facial acne. The purpose of this study is to evaluate 3 different doses of an investigational topical acne medication as compared to placebo (inactive substance). Participants have 5 visits over approximately 14 weeks and are compensated up to $750.00 for time and travel.